Page last updated: 2024-11-06

hydroxyproline and Hematologic Neoplasms

hydroxyproline has been researched along with Hematologic Neoplasms in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Research Excerpts

ExcerptRelevanceReference
"Osteoporosis is a common disease among patients undergoing transplantation."1.30Reduction of bone mass in women after bone marrow transplantation. ( Arranz, R; Carmona, L; Carvajal, I; Castañeda, S; Díaz, A; García-Vadillo, A, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castañeda, S1
Carmona, L1
Carvajal, I1
Arranz, R1
Díaz, A1
García-Vadillo, A1

Other Studies

1 other study available for hydroxyproline and Hematologic Neoplasms

ArticleYear
Reduction of bone mass in women after bone marrow transplantation.
    Calcified tissue international, 1997, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Marrow Transplantation;

1997